MDM2 and glioblastoma: The insurgence/progression of GBM, as well as the related chemoresistance, have often been attributed to the altered functioning of the p53 tumor suppressor derived by modifications within the p53 signaling pathway, including the overexpression of Murine Double Minute-2 (MDM2) [73,74].